208 related articles for article (PubMed ID: 15914492)
1. Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003.
Murray A; Coia JE; Mather H; Brown DJ
J Antimicrob Chemother; 2005 Jul; 56(1):110-4. PubMed ID: 15914492
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.
Albayrak F; Cokca F; Erdem B; Aysev AD
Int J Antimicrob Agents; 2004 Apr; 23(4):332-6. PubMed ID: 15081080
[TBL] [Abstract][Full Text] [Related]
3. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
Ercis S; Erdem B; Hasçelik G; Gür D
Jpn J Infect Dis; 2006 Apr; 59(2):117-9. PubMed ID: 16632912
[TBL] [Abstract][Full Text] [Related]
4. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
5. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
6. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones.
Rodriguez-Avial I; Rodriguez-Avial C; López O; Picazo JJ
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):261-4. PubMed ID: 15893900
[TBL] [Abstract][Full Text] [Related]
7. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance.
Choi SH; Woo JH; Lee JE; Park SJ; Choo EJ; Kwak YG; Kim MN; Choi MS; Lee NY; Lee BK; Kim NJ; Jeong JY; Ryu J; Kim YS
J Antimicrob Chemother; 2005 Dec; 56(6):1111-4. PubMed ID: 16244086
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance in non-typhoidal Salmonella from human sources, Spain, 2001-2003.
Soler P; González-Sanz R; Bleda MJ; Hernández G; Echeíta A; Usera MA
J Antimicrob Chemother; 2006 Aug; 58(2):310-4. PubMed ID: 16735424
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility.
Escribano I; Rodríguez JC; Royo G
Int J Antimicrob Agents; 2004 Sep; 24(3):300-3. PubMed ID: 15325438
[TBL] [Abstract][Full Text] [Related]
10. [Susceptibility to quinolones of Salmonella isolated from men and animals].
Avril JL; Couete I; Travert MF; Autuly F; Plessis P
Pathol Biol (Paris); 1995 Apr; 43(4):270-3. PubMed ID: 7567113
[TBL] [Abstract][Full Text] [Related]
11. [Quinolone resistance in Salmonella enterica].
Seral C; López L; Castillo FJ; Clavel A; Rubio MC
Rev Esp Quimioter; 1998 Mar; 11(1):43-6. PubMed ID: 9795288
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman M; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility patterns and serotypes of non-typhoidal salmonella in Trinidad.
Orrett FA; Shurland SM
Saudi Med J; 2001 Oct; 22(10):852-5. PubMed ID: 11744940
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance and class 1 integron patterns of non-typhoidal human Salmonella serotypes isolated in Hungary in 2002 and 2003.
Nógrády N; Gadó I; Tóth A; Pászti J
Int J Antimicrob Agents; 2005 Aug; 26(2):126-32. PubMed ID: 15955673
[TBL] [Abstract][Full Text] [Related]
15. Fluroquinolone resistance in typhoidal Salmonella and its detection by nalidixic acid disc diffusion.
Anjum P; Qureshi AH; Rafi S
J Pak Med Assoc; 2004 Jun; 54(6):295-301. PubMed ID: 15366793
[TBL] [Abstract][Full Text] [Related]
16. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
17. [Antimicrobial drug resistance in non-typhi Salmonellae in Castilla y Leon].
Delgado Ronda M; Munoz Bellido JL; Ibanez Perez R; Garcia Garcia MI; Serrano Heranz R; Munoz Criado S; Garcia Rodriguez JA
Rev Esp Quimioter; 2004 Mar; 17(1):29-36. PubMed ID: 15201921
[TBL] [Abstract][Full Text] [Related]
18. Assessment of factors contributing to changes in the incidence of antimicrobial drug resistance in Salmonella enterica serotypes Enteritidis and Typhimurium from humans in England and Wales in 2000, 2002 and 2004.
Threlfall EJ; Day M; de Pinna E; Charlett A; Goodyear KL
Int J Antimicrob Agents; 2006 Nov; 28(5):389-95. PubMed ID: 17029756
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Campylobacter hyointestinalis subsp. hyointestinalis to antimicrobial agents and characterization of quinolone-resistant strains.
Laatu M; Rautelin H; Hänninen ML
J Antimicrob Chemother; 2005 Feb; 55(2):182-7. PubMed ID: 15649999
[TBL] [Abstract][Full Text] [Related]
20. Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients.
Hakanen AJ; Kotilainen P; Pitkänen S; Huikko S; Siitonen A; Huovinen P
J Antimicrob Chemother; 2006 Mar; 57(3):569-72. PubMed ID: 16436543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
